A MYELOFIBROSIS CASE THAT DEVELOPS MYCOBACTERIUM INFECTION AFTER RUXOLITINIB TREATMENT

被引：0
|
作者：
Malkan, U. [1 ]
Gunes, G. [1 ]
Okay, M. [1 ]
Haznedaroglu, I. [1 ]
机构：
[1] Hacettepe Univ, Sch Med, Dept Hematol, Ankara, Turkey
来源：
LEUKEMIA RESEARCH | 2016年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OP-3
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [31] Ruxolitinib for the treatment of myelofibrosis: its clinical potential
    Ostojic, Alen
    Vrhovac, Radovan
    Verstovsek, Srdan
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 95 - 103
  • [32] A Review of Ruxolitinib for the Treatment of Myelofibrosis: A Critique of the Evidence
    Wade, Ros
    Hodgson, Robert
    Biswas, Mousumi
    Harden, Melissa
    Woolacott, Nerys
    PHARMACOECONOMICS, 2017, 35 (02) : 203 - 213
  • [33] Definition and management of ruxolitinib treatment failure in myelofibrosis
    A Pardanani
    A Tefferi
    Blood Cancer Journal, 2014, 4 : e268 - e268
  • [34] Development of Autoimmune Hemolytic Anemia During Ruxolitinib Treatment for Myelofibrosis: A Case Series
    Turgutkaya, Atakan
    Bolaman, Ali Zahit
    Yavasoglu, Irfan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, : 436 - 438
  • [35] Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
    Yan Beauverd
    Kaveh Samii
    International Journal of Hematology, 2014, 100 : 498 - 501
  • [36] Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series
    Palandri, F.
    Branzanti, F.
    Benevolo, G.
    Beggiato, E.
    Morsia, E.
    Dedola, A.
    Loffredo, M.
    Fontana, G.
    Palumbo, G. A.
    Breccia, M.
    Tiribelli, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1605 - 1609
  • [37] Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation
    Newberry, Kate J.
    Patel, Keyur
    Masarova, Lucia
    Luthra, Rajyalakshmi
    Manshouri, Taghi
    Jabbour, Elias
    Bose, Prithviraj
    Daver, Naval
    Cortes, Jorge
    Kantarjian, Hagop
    Verstovsek, Srdan
    BLOOD, 2017, 130 (09) : 1125 - 1131
  • [38] Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
    Beauverd, Yan
    Samii, Kaveh
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (05) : 498 - 501
  • [39] Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
    Ayh, Meltem
    Ozcan, Muhit
    Seval, Guldane Cengiz
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 180 - 183
  • [40] Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis
    Tefferi, Ayalew
    Begna, Kebede
    Hogan, William J.
    Litzow, Mark R.
    Hanson, Curtis A.
    Pardanani, Animesh
    BLOOD, 2011, 118 (21) : 764 - 764
12345